Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Douxfils

Showing results (121-130 of 221) with videos related to

Pageof 23
Sort By:
Journal of Clinical Medicine|June 28, 2023
Estetrol Is Safe and Well Tolerated during Treatment of Hospitalized Men and Women with Moderate COVID-19 in a Randomized, Double-Blind StudyJean Michel Foidart, Krzysztof Simon, Wulf H Utian, et al.
International Journal of Laboratory Hematology|September 28, 2021
Study of in vitro thrombin generation after neutralization of heparinMichael Hardy, Jonathan Douxfils, Laure Morimont, et al.
Journal of Thrombosis and Haemostasis : JTH|June 20, 2025
Effect of heparins, direct oral anticoagulants, and factor XII/factor XI inhibitors on catheter-initiated thrombin generation in platelet-rich plasma: an in vitro studyMichael Hardy, Henri Thonon, Jonathan Douxfils, et al.
Vaccines|August 28, 2021
Efficient Maternal to Neonate Transfer of Neutralizing Antibodies after SARS-CoV-2 Vaccination with BNT162b2: A Case-Report and Discussion of the LiteratureJonathan Douxfils, Constant Gillot, Émilie De Gottal, et al.
Thrombosis and Haemostasis|June 12, 2018
Betrixaban: Impact on Routine and Specific Coagulation Assays-A Practical Laboratory GuideRomain Siriez, Jonathan Evrard, Jean-Michel Dogné, et al.
Clinical Chemistry and Laboratory Medicine|March 31, 2023
Peri-infection titers of neutralizing and binding antibodies as a predictor of COVID-19 breakthrough infections in vaccinated healthcare professionals: importance of the timingConstant Gillot, Jean-Louis Bayart, Mélanie Closset, et al.
Thrombosis Research|May 18, 2024
The DOAC (direct oral anticoagulant) Dipstick reliably excludes residual FXa inhibitors levels in the preoperative settingJulie Vassart, Alfonso Tafur, Marisa Durante, et al.
Research and Practice in Thrombosis and Haemostasis|April 15, 2022
Analytical performance of the endogenous thrombin potential-based activated protein C resistance assay on the automated ST Genesia systemLaure Morimont, Charline Leclercq, Marie Didembourg, et al.
Clinical Chemistry and Laboratory Medicine|August 25, 2019
Validation and standardization of the ETP-based activated protein C resistance test for the clinical investigation of steroid contraceptives in women: an unmet clinical and regulatory needJonathan Douxfils, Laure Morimont, Anne-Sophie Delvigne, et al.
Contraception|March 2, 2025
Estetrol/Drospirenone safety in a population with cardiovascular risk factorsMitchell D Creinin, Jean Michel Foidart, Kristina Gemzell-Danielsson, et al.
Pageof 23

Showing results (121-130 of 221) with videos related to

Sort By:
Pageof 23
Journal of Clinical Medicine|June 28, 2023
Estetrol Is Safe and Well Tolerated during Treatment of Hospitalized Men and Women with Moderate COVID-19 in a Randomized, Double-Blind StudyJean Michel Foidart, Krzysztof Simon, Wulf H Utian, et al.
International Journal of Laboratory Hematology|September 28, 2021
Study of in vitro thrombin generation after neutralization of heparinMichael Hardy, Jonathan Douxfils, Laure Morimont, et al.
Journal of Thrombosis and Haemostasis : JTH|June 20, 2025
Effect of heparins, direct oral anticoagulants, and factor XII/factor XI inhibitors on catheter-initiated thrombin generation in platelet-rich plasma: an in vitro studyMichael Hardy, Henri Thonon, Jonathan Douxfils, et al.
Vaccines|August 28, 2021
Efficient Maternal to Neonate Transfer of Neutralizing Antibodies after SARS-CoV-2 Vaccination with BNT162b2: A Case-Report and Discussion of the LiteratureJonathan Douxfils, Constant Gillot, Émilie De Gottal, et al.
Thrombosis and Haemostasis|June 12, 2018
Betrixaban: Impact on Routine and Specific Coagulation Assays-A Practical Laboratory GuideRomain Siriez, Jonathan Evrard, Jean-Michel Dogné, et al.
Clinical Chemistry and Laboratory Medicine|March 31, 2023
Peri-infection titers of neutralizing and binding antibodies as a predictor of COVID-19 breakthrough infections in vaccinated healthcare professionals: importance of the timingConstant Gillot, Jean-Louis Bayart, Mélanie Closset, et al.
Thrombosis Research|May 18, 2024
The DOAC (direct oral anticoagulant) Dipstick reliably excludes residual FXa inhibitors levels in the preoperative settingJulie Vassart, Alfonso Tafur, Marisa Durante, et al.
Research and Practice in Thrombosis and Haemostasis|April 15, 2022
Analytical performance of the endogenous thrombin potential-based activated protein C resistance assay on the automated ST Genesia systemLaure Morimont, Charline Leclercq, Marie Didembourg, et al.
Clinical Chemistry and Laboratory Medicine|August 25, 2019
Validation and standardization of the ETP-based activated protein C resistance test for the clinical investigation of steroid contraceptives in women: an unmet clinical and regulatory needJonathan Douxfils, Laure Morimont, Anne-Sophie Delvigne, et al.
Contraception|March 2, 2025
Estetrol/Drospirenone safety in a population with cardiovascular risk factorsMitchell D Creinin, Jean Michel Foidart, Kristina Gemzell-Danielsson, et al.
Pageof 23